| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 95 | 2024 | 3976 | 9.220 |
Why?
|
| Oropharyngeal Neoplasms | 49 | 2023 | 1105 | 5.970 |
Why?
|
| Radiation Oncology | 36 | 2023 | 529 | 5.850 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 52 | 2024 | 2370 | 4.730 |
Why?
|
| Radiotherapy, Intensity-Modulated | 52 | 2024 | 2104 | 4.040 |
Why?
|
| Carcinoma, Squamous Cell | 40 | 2022 | 5437 | 3.330 |
Why?
|
| Deglutition Disorders | 21 | 2023 | 447 | 2.860 |
Why?
|
| Organs at Risk | 17 | 2023 | 514 | 2.630 |
Why?
|
| Laryngeal Neoplasms | 10 | 2019 | 518 | 2.560 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2024 | 7702 | 2.470 |
Why?
|
| Image Processing, Computer-Assisted | 18 | 2023 | 1648 | 2.220 |
Why?
|
| Nasopharyngeal Neoplasms | 6 | 2022 | 323 | 1.680 |
Why?
|
| Radiotherapy, Image-Guided | 12 | 2024 | 304 | 1.640 |
Why?
|
| Software | 13 | 2021 | 1321 | 1.620 |
Why?
|
| Tomography, X-Ray Computed | 32 | 2023 | 7551 | 1.580 |
Why?
|
| Biomedical Research | 6 | 2024 | 806 | 1.410 |
Why?
|
| Artificial Intelligence | 9 | 2023 | 388 | 1.350 |
Why?
|
| Humans | 270 | 2024 | 261506 | 1.320 |
Why?
|
| Algorithms | 22 | 2022 | 3890 | 1.310 |
Why?
|
| Publications | 4 | 2016 | 54 | 1.300 |
Why?
|
| Radiotherapy Dosage | 42 | 2023 | 3842 | 1.260 |
Why?
|
| Bibliometrics | 7 | 2023 | 71 | 1.210 |
Why?
|
| Radiation Injuries | 18 | 2020 | 1411 | 1.210 |
Why?
|
| Papillomavirus Infections | 10 | 2023 | 980 | 1.190 |
Why?
|
| Osteoradionecrosis | 7 | 2022 | 123 | 1.170 |
Why?
|
| Radiotherapy, Conformal | 12 | 2020 | 902 | 1.170 |
Why?
|
| Tumor Burden | 14 | 2024 | 1987 | 1.140 |
Why?
|
| Quality Assurance, Health Care | 9 | 2019 | 585 | 1.100 |
Why?
|
| Radiotherapy | 10 | 2018 | 1824 | 1.090 |
Why?
|
| Chemoradiotherapy | 12 | 2021 | 1946 | 1.030 |
Why?
|
| Carcinoma | 11 | 2023 | 2578 | 0.990 |
Why?
|
| Re-Irradiation | 8 | 2021 | 163 | 0.940 |
Why?
|
| Neoplasm Recurrence, Local | 29 | 2023 | 10035 | 0.940 |
Why?
|
| Efficiency | 6 | 2018 | 99 | 0.900 |
Why?
|
| Middle Aged | 108 | 2021 | 86204 | 0.890 |
Why?
|
| Male | 128 | 2022 | 123000 | 0.880 |
Why?
|
| Sarcopenia | 3 | 2022 | 110 | 0.870 |
Why?
|
| Aged | 101 | 2022 | 70117 | 0.870 |
Why?
|
| Radiotherapy, Adjuvant | 12 | 2018 | 2231 | 0.860 |
Why?
|
| Radiotherapy Setup Errors | 5 | 2020 | 80 | 0.860 |
Why?
|
| Retrospective Studies | 77 | 2024 | 37905 | 0.860 |
Why?
|
| Faculty, Medical | 3 | 2014 | 289 | 0.850 |
Why?
|
| Neoplasms | 20 | 2023 | 15193 | 0.850 |
Why?
|
| Prospective Studies | 32 | 2023 | 12873 | 0.840 |
Why?
|
| Laryngectomy | 4 | 2017 | 242 | 0.840 |
Why?
|
| Female | 135 | 2023 | 141928 | 0.840 |
Why?
|
| Musculoskeletal Manipulations | 1 | 2021 | 12 | 0.810 |
Why?
|
| Mentors | 2 | 2014 | 203 | 0.810 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2019 | 592 | 0.810 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2020 | 133 | 0.810 |
Why?
|
| Xerostomia | 7 | 2022 | 190 | 0.780 |
Why?
|
| Aged, 80 and over | 57 | 2021 | 29902 | 0.760 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 6 | 2023 | 341 | 0.760 |
Why?
|
| Neutrophils | 2 | 2022 | 835 | 0.760 |
Why?
|
| Benchmarking | 4 | 2021 | 273 | 0.750 |
Why?
|
| Phantoms, Imaging | 9 | 2020 | 1271 | 0.750 |
Why?
|
| Internship and Residency | 7 | 2021 | 1375 | 0.730 |
Why?
|
| Diagnostic Imaging | 5 | 2021 | 1162 | 0.730 |
Why?
|
| Ferrosoferric Oxide | 1 | 2020 | 40 | 0.710 |
Why?
|
| Adult | 84 | 2021 | 77950 | 0.710 |
Why?
|
| Ferric Compounds | 1 | 2020 | 73 | 0.700 |
Why?
|
| Cancer Survivors | 9 | 2022 | 650 | 0.680 |
Why?
|
| Markov Chains | 1 | 2019 | 175 | 0.680 |
Why?
|
| Positron-Emission Tomography | 9 | 2019 | 2173 | 0.680 |
Why?
|
| Gallbladder Neoplasms | 5 | 2015 | 245 | 0.670 |
Why?
|
| Nomograms | 2 | 2018 | 313 | 0.640 |
Why?
|
| Radiosurgery | 9 | 2021 | 1330 | 0.640 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 164 | 0.630 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2021 | 607 | 0.600 |
Why?
|
| Patient Positioning | 3 | 2019 | 195 | 0.600 |
Why?
|
| Prognosis | 33 | 2024 | 21713 | 0.600 |
Why?
|
| Patient Reported Outcome Measures | 10 | 2022 | 799 | 0.590 |
Why?
|
| Pharyngeal Muscles | 2 | 2018 | 36 | 0.590 |
Why?
|
| Thymoma | 3 | 2010 | 246 | 0.590 |
Why?
|
| Survival Analysis | 21 | 2020 | 9180 | 0.580 |
Why?
|
| Disease-Free Survival | 22 | 2023 | 10001 | 0.570 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 502 | 0.560 |
Why?
|
| Research Support as Topic | 4 | 2020 | 122 | 0.560 |
Why?
|
| Publishing | 3 | 2018 | 220 | 0.560 |
Why?
|
| Clinical Protocols | 1 | 2018 | 467 | 0.550 |
Why?
|
| Thymus Neoplasms | 3 | 2010 | 400 | 0.530 |
Why?
|
| Quality of Life | 13 | 2022 | 4532 | 0.530 |
Why?
|
| Papillomaviridae | 6 | 2020 | 624 | 0.510 |
Why?
|
| Physicians | 4 | 2022 | 882 | 0.510 |
Why?
|
| Nose Neoplasms | 3 | 2023 | 229 | 0.500 |
Why?
|
| Vomiting | 2 | 2014 | 354 | 0.500 |
Why?
|
| Cachexia | 1 | 2016 | 161 | 0.500 |
Why?
|
| Robotic Surgical Procedures | 4 | 2022 | 481 | 0.490 |
Why?
|
| Nausea | 2 | 2014 | 525 | 0.490 |
Why?
|
| Workflow | 5 | 2023 | 275 | 0.490 |
Why?
|
| Brachial Plexus | 1 | 2014 | 45 | 0.490 |
Why?
|
| Bile Duct Neoplasms | 2 | 2009 | 493 | 0.490 |
Why?
|
| Feasibility Studies | 9 | 2022 | 2292 | 0.490 |
Why?
|
| Mouth Neoplasms | 5 | 2022 | 713 | 0.480 |
Why?
|
| Cone-Beam Computed Tomography | 6 | 2020 | 202 | 0.480 |
Why?
|
| Positron Emission Tomography Computed Tomography | 6 | 2019 | 833 | 0.480 |
Why?
|
| Forecasting | 4 | 2022 | 694 | 0.480 |
Why?
|
| Career Choice | 3 | 2024 | 232 | 0.470 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 2023 | 285 | 0.460 |
Why?
|
| Deglutition | 6 | 2022 | 171 | 0.450 |
Why?
|
| Cohort Studies | 19 | 2023 | 9244 | 0.450 |
Why?
|
| Neoplasm Staging | 24 | 2023 | 13658 | 0.440 |
Why?
|
| Carcinoma, Adenoid Cystic | 4 | 2024 | 421 | 0.420 |
Why?
|
| Microsurgery | 1 | 2014 | 244 | 0.420 |
Why?
|
| Treatment Outcome | 29 | 2022 | 32848 | 0.420 |
Why?
|
| Career Mobility | 4 | 2019 | 95 | 0.410 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 361 | 0.410 |
Why?
|
| Skull Base Neoplasms | 4 | 2020 | 314 | 0.410 |
Why?
|
| Computers | 1 | 2011 | 141 | 0.400 |
Why?
|
| Reproducibility of Results | 11 | 2023 | 6009 | 0.400 |
Why?
|
| X-Rays | 3 | 2015 | 146 | 0.400 |
Why?
|
| Maxillary Sinus Neoplasms | 2 | 2023 | 117 | 0.400 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2011 | 61 | 0.400 |
Why?
|
| Thoracic Cavity | 2 | 2021 | 10 | 0.390 |
Why?
|
| Crowdsourcing | 2 | 2023 | 21 | 0.390 |
Why?
|
| Memory Disorders | 2 | 2017 | 295 | 0.390 |
Why?
|
| Dose-Response Relationship, Radiation | 8 | 2019 | 726 | 0.390 |
Why?
|
| Alphapapillomavirus | 4 | 2020 | 171 | 0.380 |
Why?
|
| Mandibular Diseases | 2 | 2021 | 45 | 0.380 |
Why?
|
| Proton Therapy | 6 | 2019 | 1577 | 0.380 |
Why?
|
| Machine Learning | 3 | 2022 | 319 | 0.380 |
Why?
|
| Survivors | 7 | 2022 | 1031 | 0.370 |
Why?
|
| Thyroid Carcinoma, Anaplastic | 3 | 2019 | 259 | 0.370 |
Why?
|
| Precision Medicine | 1 | 2018 | 1154 | 0.370 |
Why?
|
| Laser Therapy | 1 | 2014 | 411 | 0.370 |
Why?
|
| Surveys and Questionnaires | 12 | 2021 | 5687 | 0.360 |
Why?
|
| Particle Accelerators | 3 | 2021 | 352 | 0.360 |
Why?
|
| Radiometry | 8 | 2019 | 980 | 0.360 |
Why?
|
| Analysis of Variance | 7 | 2020 | 2307 | 0.360 |
Why?
|
| Observer Variation | 6 | 2022 | 671 | 0.360 |
Why?
|
| Computational Biology | 4 | 2021 | 1271 | 0.360 |
Why?
|
| Biomarkers | 4 | 2023 | 5047 | 0.360 |
Why?
|
| Lung Neoplasms | 11 | 2024 | 11538 | 0.350 |
Why?
|
| Survival Rate | 19 | 2022 | 12221 | 0.350 |
Why?
|
| Carcinoma, Merkel Cell | 4 | 2015 | 155 | 0.350 |
Why?
|
| Neoadjuvant Therapy | 3 | 2019 | 4975 | 0.340 |
Why?
|
| Larynx | 3 | 2020 | 134 | 0.340 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2009 | 38 | 0.340 |
Why?
|
| United States | 17 | 2024 | 15433 | 0.340 |
Why?
|
| Internet | 1 | 2014 | 706 | 0.340 |
Why?
|
| Combined Modality Therapy | 18 | 2021 | 8865 | 0.340 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2009 | 126 | 0.340 |
Why?
|
| Radiation Oncologists | 2 | 2019 | 29 | 0.340 |
Why?
|
| Genomics | 2 | 2019 | 2738 | 0.330 |
Why?
|
| Pilot Projects | 5 | 2023 | 2803 | 0.330 |
Why?
|
| Tonsillar Neoplasms | 2 | 2021 | 80 | 0.330 |
Why?
|
| Oropharynx | 2 | 2020 | 74 | 0.320 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2018 | 489 | 0.320 |
Why?
|
| Printing, Three-Dimensional | 2 | 2020 | 129 | 0.320 |
Why?
|
| Rectal Neoplasms | 3 | 2014 | 1202 | 0.310 |
Why?
|
| Lymphocytes | 3 | 2022 | 1234 | 0.310 |
Why?
|
| Brain Stem | 2 | 2023 | 175 | 0.300 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2018 | 925 | 0.300 |
Why?
|
| Neoplasm Invasiveness | 6 | 2018 | 3981 | 0.290 |
Why?
|
| Time Factors | 16 | 2024 | 12926 | 0.290 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2021 | 6207 | 0.290 |
Why?
|
| Biomarkers, Tumor | 6 | 2021 | 10331 | 0.280 |
Why?
|
| Central Nervous System | 2 | 2017 | 436 | 0.280 |
Why?
|
| Fluorodeoxyglucose F18 | 5 | 2019 | 1226 | 0.280 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 5539 | 0.280 |
Why?
|
| Radiography | 7 | 2016 | 1904 | 0.280 |
Why?
|
| Parotid Gland | 3 | 2020 | 112 | 0.270 |
Why?
|
| Organ Sparing Treatments | 3 | 2019 | 277 | 0.270 |
Why?
|
| Anus Neoplasms | 1 | 2010 | 411 | 0.270 |
Why?
|
| Catheterization | 2 | 2005 | 410 | 0.270 |
Why?
|
| Lymphatic Metastasis | 10 | 2021 | 4844 | 0.270 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 2 | 2017 | 110 | 0.270 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2019 | 1833 | 0.270 |
Why?
|
| Registries | 7 | 2021 | 2170 | 0.260 |
Why?
|
| Mandible | 3 | 2022 | 188 | 0.260 |
Why?
|
| Follow-Up Studies | 16 | 2019 | 14889 | 0.260 |
Why?
|
| Skull Base | 4 | 2020 | 199 | 0.260 |
Why?
|
| Enteral Nutrition | 2 | 2018 | 316 | 0.260 |
Why?
|
| Cholangiocarcinoma | 2 | 2009 | 493 | 0.260 |
Why?
|
| Tongue Neoplasms | 2 | 2020 | 246 | 0.250 |
Why?
|
| Dental Alloys | 1 | 2004 | 7 | 0.250 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 476 | 0.250 |
Why?
|
| Glottis | 2 | 2019 | 67 | 0.250 |
Why?
|
| Neck | 2 | 2019 | 383 | 0.250 |
Why?
|
| Weight Loss | 3 | 2018 | 627 | 0.250 |
Why?
|
| Lactic Acid | 2 | 2017 | 305 | 0.250 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 4314 | 0.250 |
Why?
|
| Academic Medical Centers | 4 | 2019 | 672 | 0.240 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2020 | 406 | 0.240 |
Why?
|
| Risk Assessment | 9 | 2023 | 6869 | 0.240 |
Why?
|
| Young Adult | 20 | 2021 | 21445 | 0.240 |
Why?
|
| Treatment Failure | 5 | 2023 | 1391 | 0.240 |
Why?
|
| Radiation Dosage | 5 | 2020 | 1014 | 0.240 |
Why?
|
| Proportional Hazards Models | 7 | 2019 | 4988 | 0.240 |
Why?
|
| Cell Proliferation | 1 | 2016 | 7226 | 0.230 |
Why?
|
| Urethral Neoplasms | 1 | 2003 | 60 | 0.230 |
Why?
|
| Glioblastoma | 3 | 2018 | 1797 | 0.230 |
Why?
|
| Lymph Nodes | 5 | 2021 | 2967 | 0.230 |
Why?
|
| Contrast Media | 2 | 2020 | 1472 | 0.230 |
Why?
|
| Salvage Therapy | 5 | 2022 | 2054 | 0.230 |
Why?
|
| Muscle, Skeletal | 4 | 2022 | 1270 | 0.230 |
Why?
|
| Orbital Neoplasms | 2 | 2015 | 224 | 0.230 |
Why?
|
| Stents | 2 | 2020 | 1096 | 0.230 |
Why?
|
| Immobilization | 3 | 2020 | 93 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2020 | 5319 | 0.220 |
Why?
|
| Computer Simulation | 7 | 2018 | 1529 | 0.220 |
Why?
|
| Echo-Planar Imaging | 1 | 2023 | 73 | 0.220 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 4298 | 0.220 |
Why?
|
| Adenocarcinoma | 4 | 2016 | 7789 | 0.220 |
Why?
|
| Thyroid Neoplasms | 3 | 2019 | 1866 | 0.210 |
Why?
|
| Tinnitus | 1 | 2022 | 38 | 0.210 |
Why?
|
| Cognition Disorders | 1 | 2008 | 786 | 0.210 |
Why?
|
| Paranasal Sinuses | 1 | 2022 | 61 | 0.210 |
Why?
|
| Radiodermatitis | 2 | 2019 | 75 | 0.210 |
Why?
|
| Texas | 10 | 2021 | 6311 | 0.210 |
Why?
|
| Awards and Prizes | 1 | 2023 | 98 | 0.210 |
Why?
|
| Prostatic Neoplasms | 4 | 2020 | 5767 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 9 | 2020 | 15862 | 0.200 |
Why?
|
| Conservation of Natural Resources | 1 | 2021 | 17 | 0.200 |
Why?
|
| Conflict of Interest | 2 | 2020 | 98 | 0.200 |
Why?
|
| Voice Disorders | 1 | 2021 | 39 | 0.200 |
Why?
|
| Smoking | 4 | 2020 | 2440 | 0.200 |
Why?
|
| Research Design | 2 | 2020 | 1544 | 0.200 |
Why?
|
| Medical Writing | 1 | 2020 | 5 | 0.190 |
Why?
|
| Speech Disorders | 1 | 2021 | 91 | 0.190 |
Why?
|
| Hematologic Tests | 1 | 2021 | 82 | 0.190 |
Why?
|
| Nasal Cavity | 2 | 2022 | 149 | 0.190 |
Why?
|
| Magnesium Deficiency | 1 | 2020 | 21 | 0.190 |
Why?
|
| Linear Models | 2 | 2014 | 1085 | 0.190 |
Why?
|
| Hearing Loss | 1 | 2022 | 153 | 0.190 |
Why?
|
| Lymphatic Diseases | 1 | 2021 | 128 | 0.190 |
Why?
|
| Trismus | 1 | 2020 | 24 | 0.190 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2020 | 447 | 0.180 |
Why?
|
| SEER Program | 3 | 2008 | 1000 | 0.180 |
Why?
|
| Pharynx | 2 | 2019 | 153 | 0.180 |
Why?
|
| Insurance Coverage | 2 | 2020 | 256 | 0.170 |
Why?
|
| Statistics, Nonparametric | 3 | 2020 | 980 | 0.170 |
Why?
|
| Multimodal Imaging | 1 | 2023 | 550 | 0.170 |
Why?
|
| Social Media | 1 | 2023 | 203 | 0.170 |
Why?
|
| Hypopharyngeal Neoplasms | 2 | 2017 | 82 | 0.170 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 4849 | 0.170 |
Why?
|
| Salivary Glands | 1 | 2019 | 130 | 0.170 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2023 | 208 | 0.170 |
Why?
|
| Fatigue | 5 | 2022 | 1239 | 0.170 |
Why?
|
| Thyroidectomy | 2 | 2019 | 486 | 0.170 |
Why?
|
| Medicine | 1 | 2021 | 137 | 0.170 |
Why?
|
| Cancer Care Facilities | 4 | 2016 | 884 | 0.170 |
Why?
|
| Double-Blind Method | 3 | 2016 | 2588 | 0.170 |
Why?
|
| Risk Factors | 7 | 2022 | 17523 | 0.170 |
Why?
|
| Motion | 2 | 2018 | 193 | 0.170 |
Why?
|
| Industry | 1 | 2018 | 53 | 0.160 |
Why?
|
| Standard of Care | 1 | 2020 | 243 | 0.160 |
Why?
|
| Pleural Effusion | 1 | 2020 | 201 | 0.160 |
Why?
|
| Age Factors | 6 | 2020 | 5377 | 0.160 |
Why?
|
| Clinical Competence | 2 | 2016 | 1270 | 0.160 |
Why?
|
| Computer Graphics | 1 | 2018 | 82 | 0.160 |
Why?
|
| Bayes Theorem | 5 | 2021 | 1021 | 0.160 |
Why?
|
| Depression | 1 | 2008 | 1715 | 0.160 |
Why?
|
| Liquid Biopsy | 1 | 2018 | 158 | 0.160 |
Why?
|
| Fibrosis | 1 | 2021 | 793 | 0.160 |
Why?
|
| Trigeminal Neuralgia | 1 | 2018 | 42 | 0.160 |
Why?
|
| Metastasectomy | 1 | 2020 | 200 | 0.160 |
Why?
|
| Societies, Scientific | 1 | 2017 | 74 | 0.150 |
Why?
|
| Respiratory Muscles | 1 | 2017 | 27 | 0.150 |
Why?
|
| Lymphopenia | 1 | 2020 | 199 | 0.150 |
Why?
|
| Neoplasm, Residual | 3 | 2018 | 1656 | 0.150 |
Why?
|
| Cisplatin | 5 | 2020 | 2432 | 0.150 |
Why?
|
| Dura Mater | 1 | 2017 | 73 | 0.150 |
Why?
|
| Minocycline | 1 | 2019 | 182 | 0.150 |
Why?
|
| Exhalation | 1 | 2017 | 60 | 0.150 |
Why?
|
| Reference Standards | 2 | 2017 | 339 | 0.150 |
Why?
|
| Neck Dissection | 2 | 2019 | 290 | 0.150 |
Why?
|
| Radiopharmaceuticals | 3 | 2019 | 1301 | 0.150 |
Why?
|
| Body Composition | 2 | 2021 | 595 | 0.150 |
Why?
|
| Vocal Cords | 1 | 2018 | 90 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 279 | 0.150 |
Why?
|
| Cluster Analysis | 4 | 2023 | 1053 | 0.150 |
Why?
|
| Medical Oncology | 2 | 2023 | 1423 | 0.150 |
Why?
|
| Probability | 3 | 2021 | 866 | 0.150 |
Why?
|
| Gastrostomy | 1 | 2018 | 180 | 0.150 |
Why?
|
| Brachytherapy | 4 | 2016 | 977 | 0.150 |
Why?
|
| Muscle Strength | 1 | 2017 | 104 | 0.150 |
Why?
|
| Barium | 1 | 2016 | 26 | 0.140 |
Why?
|
| Incidence | 5 | 2023 | 5673 | 0.140 |
Why?
|
| Olfactory Bulb | 1 | 2017 | 119 | 0.140 |
Why?
|
| Thorax | 1 | 2017 | 213 | 0.140 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2016 | 79 | 0.140 |
Why?
|
| Peer Review | 1 | 2016 | 80 | 0.140 |
Why?
|
| Self Report | 5 | 2020 | 756 | 0.140 |
Why?
|
| Palate, Soft | 1 | 2016 | 28 | 0.140 |
Why?
|
| Kinetics | 2 | 2018 | 2049 | 0.140 |
Why?
|
| Eating | 1 | 2018 | 421 | 0.140 |
Why?
|
| Comorbidity | 3 | 2018 | 2352 | 0.140 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2018 | 192 | 0.140 |
Why?
|
| Automation | 2 | 2020 | 151 | 0.130 |
Why?
|
| Child Care | 1 | 2015 | 15 | 0.130 |
Why?
|
| Population Surveillance | 1 | 2019 | 627 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2017 | 414 | 0.130 |
Why?
|
| Vocal Cord Dysfunction | 1 | 2015 | 15 | 0.130 |
Why?
|
| Area Under Curve | 4 | 2021 | 700 | 0.130 |
Why?
|
| Databases, Factual | 4 | 2017 | 2218 | 0.130 |
Why?
|
| Models, Biological | 3 | 2019 | 3254 | 0.130 |
Why?
|
| Physical Examination | 1 | 2016 | 299 | 0.130 |
Why?
|
| Ultrasonography | 5 | 2013 | 1863 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 1 | 2019 | 423 | 0.130 |
Why?
|
| Cervical Atlas | 1 | 2014 | 19 | 0.130 |
Why?
|
| Platelet Count | 1 | 2015 | 490 | 0.120 |
Why?
|
| Exercise Therapy | 1 | 2017 | 288 | 0.120 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 1022 | 0.120 |
Why?
|
| Skin Neoplasms | 4 | 2015 | 4654 | 0.120 |
Why?
|
| Orbit | 1 | 2015 | 205 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 3 | 2018 | 3890 | 0.120 |
Why?
|
| Burnout, Professional | 1 | 2017 | 205 | 0.120 |
Why?
|
| Adolescent | 12 | 2020 | 31252 | 0.120 |
Why?
|
| Carotid Arteries | 2 | 2019 | 240 | 0.120 |
Why?
|
| Sex Factors | 3 | 2015 | 2139 | 0.120 |
Why?
|
| Informatics | 2 | 2023 | 21 | 0.120 |
Why?
|
| Prevalence | 5 | 2023 | 3260 | 0.120 |
Why?
|
| Cranial Nerve Diseases | 1 | 2014 | 73 | 0.120 |
Why?
|
| Logistic Models | 3 | 2016 | 3441 | 0.120 |
Why?
|
| Computer-Assisted Instruction | 1 | 2014 | 81 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2023 | 2594 | 0.110 |
Why?
|
| Head | 1 | 2014 | 249 | 0.110 |
Why?
|
| Rectum | 2 | 2005 | 467 | 0.110 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 333 | 0.110 |
Why?
|
| Workload | 1 | 2013 | 198 | 0.110 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 313 | 0.110 |
Why?
|
| Educational Status | 1 | 2013 | 397 | 0.110 |
Why?
|
| Brain | 2 | 2017 | 4113 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1516 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 1 | 2015 | 334 | 0.100 |
Why?
|
| Authorship | 1 | 2012 | 53 | 0.100 |
Why?
|
| Carboplatin | 3 | 2020 | 823 | 0.100 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 4320 | 0.100 |
Why?
|
| Radiation Protection | 3 | 2015 | 205 | 0.100 |
Why?
|
| Urinary Bladder | 2 | 2005 | 575 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2020 | 1546 | 0.100 |
Why?
|
| Body Weight | 1 | 2016 | 1293 | 0.100 |
Why?
|
| Thoracic Neoplasms | 1 | 2014 | 337 | 0.100 |
Why?
|
| Clinical Trials as Topic | 4 | 2020 | 3719 | 0.100 |
Why?
|
| Stomatitis | 3 | 2018 | 183 | 0.100 |
Why?
|
| Universities | 1 | 2012 | 160 | 0.100 |
Why?
|
| Technology | 2 | 2022 | 96 | 0.100 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2015 | 489 | 0.100 |
Why?
|
| Parenting | 1 | 2015 | 345 | 0.100 |
Why?
|
| Data Collection | 1 | 2013 | 620 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 5112 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2021 | 2203 | 0.100 |
Why?
|
| Students, Medical | 1 | 2016 | 399 | 0.100 |
Why?
|
| Prostate | 2 | 2006 | 1088 | 0.090 |
Why?
|
| Curriculum | 1 | 2016 | 860 | 0.090 |
Why?
|
| Medical Illustration | 1 | 2010 | 34 | 0.090 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 4971 | 0.090 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 1429 | 0.090 |
Why?
|
| Glucose | 1 | 2016 | 1248 | 0.090 |
Why?
|
| Health Status Indicators | 2 | 2017 | 224 | 0.090 |
Why?
|
| Organ Size | 1 | 2011 | 690 | 0.090 |
Why?
|
| Vagus Nerve | 1 | 2010 | 63 | 0.090 |
Why?
|
| Myelitis | 1 | 2009 | 26 | 0.090 |
Why?
|
| Melanoma | 2 | 2022 | 5317 | 0.090 |
Why?
|
| Mitomycin | 1 | 2010 | 208 | 0.090 |
Why?
|
| Models, Statistical | 3 | 2018 | 1171 | 0.090 |
Why?
|
| Cervical Vertebrae | 2 | 2020 | 205 | 0.080 |
Why?
|
| Mental Status Schedule | 1 | 2008 | 60 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2010 | 255 | 0.080 |
Why?
|
| Space Perception | 1 | 2008 | 77 | 0.080 |
Why?
|
| Sleep Wake Disorders | 3 | 2019 | 348 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 338 | 0.080 |
Why?
|
| Faculty | 1 | 2008 | 130 | 0.080 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1945 | 0.070 |
Why?
|
| Visual Perception | 1 | 2008 | 154 | 0.070 |
Why?
|
| Cetuximab | 2 | 2021 | 472 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5159 | 0.070 |
Why?
|
| Choroid Neoplasms | 1 | 2006 | 41 | 0.070 |
Why?
|
| Disease Progression | 4 | 2019 | 6682 | 0.070 |
Why?
|
| Keloid | 1 | 2006 | 14 | 0.070 |
Why?
|
| Paclitaxel | 2 | 2020 | 1996 | 0.070 |
Why?
|
| Margins of Excision | 2 | 2018 | 285 | 0.070 |
Why?
|
| Time-to-Treatment | 2 | 2019 | 292 | 0.070 |
Why?
|
| Bias | 2 | 2023 | 205 | 0.070 |
Why?
|
| Monte Carlo Method | 2 | 2006 | 671 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2009 | 690 | 0.070 |
Why?
|
| Calibration | 1 | 2006 | 337 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2008 | 429 | 0.070 |
Why?
|
| Consensus | 2 | 2023 | 978 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2022 | 6100 | 0.060 |
Why?
|
| Dental Restoration, Permanent | 1 | 2004 | 5 | 0.060 |
Why?
|
| Induction Chemotherapy | 2 | 2020 | 669 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 543 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 2403 | 0.060 |
Why?
|
| Prostheses and Implants | 1 | 2006 | 295 | 0.060 |
Why?
|
| Stereotaxic Techniques | 1 | 2004 | 172 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2008 | 1178 | 0.060 |
Why?
|
| Patient Outcome Assessment | 2 | 2015 | 245 | 0.060 |
Why?
|
| Financing, Government | 1 | 2023 | 40 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2019 | 495 | 0.060 |
Why?
|
| Postoperative Care | 2 | 2017 | 739 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2016 | 2576 | 0.060 |
Why?
|
| Journal Impact Factor | 1 | 2023 | 40 | 0.060 |
Why?
|
| Causality | 2 | 2016 | 178 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5178 | 0.060 |
Why?
|
| Abdominal Neoplasms | 1 | 2004 | 231 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2020 | 482 | 0.050 |
Why?
|
| Palliative Care | 3 | 2019 | 2037 | 0.050 |
Why?
|
| Mutation | 2 | 2019 | 15179 | 0.050 |
Why?
|
| Mandibular Osteotomy | 1 | 2022 | 33 | 0.050 |
Why?
|
| Pregnancy | 1 | 2015 | 7573 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1390 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2019 | 851 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 852 | 0.050 |
Why?
|
| Lung | 2 | 2024 | 3151 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2021 | 100 | 0.050 |
Why?
|
| Supervised Machine Learning | 1 | 2020 | 12 | 0.050 |
Why?
|
| Dental Impression Technique | 1 | 2019 | 17 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 429 | 0.040 |
Why?
|
| Parotid Diseases | 1 | 2019 | 12 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2020 | 96 | 0.040 |
Why?
|
| Radioactive Hazard Release | 1 | 2019 | 5 | 0.040 |
Why?
|
| Smokers | 1 | 2020 | 143 | 0.040 |
Why?
|
| Industrial Development | 1 | 2019 | 3 | 0.040 |
Why?
|
| Drainage | 1 | 2022 | 416 | 0.040 |
Why?
|
| ROC Curve | 1 | 2022 | 1183 | 0.040 |
Why?
|
| Medical Informatics Applications | 1 | 2019 | 21 | 0.040 |
Why?
|
| Blood Vessels | 1 | 2020 | 217 | 0.040 |
Why?
|
| Survival | 1 | 2019 | 177 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 684 | 0.040 |
Why?
|
| Rural Health Services | 1 | 2019 | 39 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 486 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2022 | 624 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2022 | 487 | 0.040 |
Why?
|
| Recurrence | 1 | 2007 | 4758 | 0.040 |
Why?
|
| Biology | 1 | 2019 | 75 | 0.040 |
Why?
|
| Range of Motion, Articular | 1 | 2019 | 144 | 0.040 |
Why?
|
| Parotid Neoplasms | 1 | 2019 | 148 | 0.040 |
Why?
|
| Gift Giving | 1 | 2018 | 25 | 0.040 |
Why?
|
| Breakthrough Pain | 1 | 2018 | 17 | 0.040 |
Why?
|
| Radiography, Interventional | 1 | 2020 | 305 | 0.040 |
Why?
|
| Posture | 1 | 2019 | 215 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 862 | 0.040 |
Why?
|
| Nonlinear Dynamics | 1 | 2018 | 78 | 0.040 |
Why?
|
| Neck Pain | 1 | 2018 | 39 | 0.040 |
Why?
|
| Oximes | 1 | 2019 | 175 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 597 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 4892 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2019 | 160 | 0.040 |
Why?
|
| Emotional Intelligence | 1 | 2017 | 14 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 452 | 0.040 |
Why?
|
| Cause of Death | 1 | 2020 | 752 | 0.040 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2018 | 75 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2018 | 232 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2019 | 314 | 0.040 |
Why?
|
| Antineoplastic Agents | 6 | 2017 | 14289 | 0.040 |
Why?
|
| Time | 1 | 2017 | 178 | 0.040 |
Why?
|
| Patient Care | 1 | 2018 | 149 | 0.040 |
Why?
|
| Mediastinum | 1 | 2019 | 268 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 698 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2022 | 769 | 0.040 |
Why?
|
| Survivorship | 1 | 2017 | 109 | 0.040 |
Why?
|
| Platinum Compounds | 1 | 2017 | 131 | 0.040 |
Why?
|
| Pyridones | 1 | 2019 | 348 | 0.040 |
Why?
|
| Teaching Rounds | 1 | 2016 | 33 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2017 | 203 | 0.040 |
Why?
|
| Medical Informatics | 1 | 2019 | 198 | 0.040 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2019 | 565 | 0.040 |
Why?
|
| Quality Control | 1 | 2017 | 457 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 418 | 0.030 |
Why?
|
| Steroids | 1 | 2018 | 356 | 0.030 |
Why?
|
| Health Policy | 1 | 2019 | 291 | 0.030 |
Why?
|
| Stress, Psychological | 2 | 2014 | 1000 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 519 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 390 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2016 | 211 | 0.030 |
Why?
|
| Necrosis | 1 | 2017 | 580 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2017 | 497 | 0.030 |
Why?
|
| Tomography, Emission-Computed | 1 | 2016 | 310 | 0.030 |
Why?
|
| Parental Leave | 1 | 2015 | 11 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2016 | 176 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 532 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 2316 | 0.030 |
Why?
|
| Hypoxia | 1 | 2018 | 443 | 0.030 |
Why?
|
| Marital Status | 1 | 2015 | 98 | 0.030 |
Why?
|
| Photons | 1 | 2018 | 507 | 0.030 |
Why?
|
| Mucositis | 1 | 2015 | 148 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 597 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2015 | 187 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 2278 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 2016 | 102 | 0.030 |
Why?
|
| Relative Biological Effectiveness | 1 | 2015 | 219 | 0.030 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2016 | 363 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2016 | 256 | 0.030 |
Why?
|
| Patient Selection | 1 | 2022 | 2055 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2016 | 556 | 0.030 |
Why?
|
| Radiobiology | 1 | 2014 | 56 | 0.030 |
Why?
|
| Lymph Node Excision | 2 | 2015 | 1959 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2014 | 78 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 953 | 0.030 |
Why?
|
| Global Health | 1 | 2019 | 657 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 750 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 754 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2014 | 209 | 0.030 |
Why?
|
| Imidazoles | 1 | 2019 | 999 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 589 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2016 | 362 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 402 | 0.030 |
Why?
|
| Eyelid Neoplasms | 1 | 2015 | 191 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2015 | 239 | 0.030 |
Why?
|
| Lacrimal Apparatus | 1 | 2015 | 181 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2015 | 267 | 0.030 |
Why?
|
| Anorexia | 1 | 2014 | 143 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1541 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 622 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2018 | 1819 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 30 | 0.030 |
Why?
|
| Radiology | 1 | 2018 | 434 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2016 | 561 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 1283 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2012 | 139 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2015 | 629 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4638 | 0.030 |
Why?
|
| Animals | 4 | 2017 | 59536 | 0.030 |
Why?
|
| Psychometrics | 1 | 2016 | 937 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 584 | 0.030 |
Why?
|
| Pneumonectomy | 1 | 2017 | 831 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2015 | 966 | 0.020 |
Why?
|
| Cognition | 1 | 2017 | 968 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2015 | 873 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 1258 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 14551 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 360 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 1742 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2014 | 498 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 2 | 2005 | 5061 | 0.020 |
Why?
|
| Pain | 1 | 2019 | 1658 | 0.020 |
Why?
|
| Diet | 1 | 2018 | 1440 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Cornea | 1 | 2015 | 638 | 0.020 |
Why?
|
| Meninges | 1 | 2009 | 47 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2009 | 145 | 0.020 |
Why?
|
| Puberty | 1 | 2009 | 104 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2009 | 257 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 4307 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2008 | 66 | 0.020 |
Why?
|
| Mass Screening | 1 | 2017 | 1509 | 0.020 |
Why?
|
| Tooth | 1 | 2008 | 14 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 6086 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3821 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 1371 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2009 | 388 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 3251 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 764 | 0.020 |
Why?
|
| Life Tables | 1 | 2007 | 120 | 0.020 |
Why?
|
| Cranial Irradiation | 1 | 2009 | 315 | 0.020 |
Why?
|
| Mandibular Neoplasms | 1 | 2008 | 76 | 0.020 |
Why?
|
| Etoposide | 1 | 2009 | 870 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 254 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2009 | 485 | 0.020 |
Why?
|
| DNA Damage | 1 | 2015 | 1954 | 0.020 |
Why?
|
| Methotrexate | 1 | 2009 | 999 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 2009 | 341 | 0.020 |
Why?
|
| Sarcoma, Ewing | 1 | 2009 | 406 | 0.020 |
Why?
|
| Perineum | 1 | 2006 | 107 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 1511 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2006 | 155 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 34495 | 0.020 |
Why?
|
| Child | 3 | 2015 | 29154 | 0.020 |
Why?
|
| Pelvis | 1 | 2006 | 362 | 0.020 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2007 | 272 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2006 | 756 | 0.020 |
Why?
|
| Spinal Neoplasms | 1 | 2009 | 631 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7222 | 0.020 |
Why?
|
| Cytarabine | 1 | 2009 | 1973 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 1323 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 3552 | 0.010 |
Why?
|
| Equipment Design | 1 | 2006 | 1204 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 1382 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 3001 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 785 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2004 | 262 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2005 | 1944 | 0.010 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2007 | 1415 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 3472 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2005 | 1299 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2004 | 686 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 4744 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 2027 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2004 | 16273 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 4557 | 0.000 |
Why?
|